Study of HeartR PDA Heart Device Safety and Function
Part of Genetic & congenital, Heart & circulation clinical trials.
This study follows patients who had a small heart device (HeartR PDA Occluder) placed to close an opening in their heart called a PDA. Researchers will check how well the device is working and track the patient's health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a PDA (a small opening in the heart) diagnosed before surgery
- You had the HeartR PDA Occluder device implanted (placed in your heart)
- You were at least 6 months old when you had the implant
- You weighed at least 6 kg (about 13 lbs) when you had the implant
- The opening in your heart was at least 2 mm wide before the device was placed
- You completed at least one follow-up visit after leaving the hospital
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
This study keeps a national record of babies with a heart connection called a PDA who are being considered for closure using a catheter procedure. It may help doctors improve how they choose treatment and devices for babies with different health needs.
This study looks at how closing a heart valve problem (patent ductus arteriosus, or PDA) using a catheter procedure affects how your heart chambers change shape and work. Researchers want to understand if this minimally invasive procedure improves heart function.
This study looks at how well children do when their PDA is closed using a catheter (a thin tube through a blood vessel). It helps doctors understand the best ways to treat this common heart condition in kids ages 6 months to 16 years.
This follow-up study monitors how well and how safely the Occlutech mVSD device works to close certain muscular heart “holes” (ventricular septal defects). You may join if you already had the device placed and can return for scheduled checkups to help doctors learn long-term outcomes.
This trial monitors children who had a ventricular septal defect (VSD) closed with a device to see how they do over time. It checks if the closure stays effective and if there are any long-term issues.
Hear when a new Patent Ductus Arteriosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.